Evaluating Arcutis Biotherapeutics: Insights From 5 Financial Analysts
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Arcutis Biotherapeutics…
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Intelligent Bio Solutions (NASDAQ:INBS) shares moved upwards by 219.4% to $9.2 during Friday’s regular session. The market…
MaxLinear Reports Q4 Results, Joins ING, Wolfspeed And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 90 points on Thursday.
Verizon Posts Upbeat Earnings, Joins RTX, Procter & Gamble And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded mixed, with the Dow Jones index falling around 70 points on Tuesday.
Arcutis Biotherapeutics, Inc. Announces ZORYVE Topical Foam, 0.3%, For The Treatment Of Seborrheic Dermatitis Launches In The United States
First drug approved for seborrheic dermatitis with a new mechanism of action in over two decades available in pharmacies this weekEffective, safe, and very well-tolerated steroid-free foam provides rapid disease
iRobot, AST SpaceMobile And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 100 points on Friday.
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Flexsteel Industries Posts Strong Preliminary Results, Joins Wipro, Sify Technologies And Other Big Stocks Moving Higher In Friday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around 50 points on Friday.
Expert Outlook: Arcutis Biotherapeutics Through The Eyes Of 7 Analysts
Ratings for Arcutis Biotherapeutics (NASDAQ:ARQT) were provided by 7 analysts in the past three months, showcasing a mix…